Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Delabeling Delayed Drug Hypersensitivity: How Far Can You Safely Go?
Rannakoe Lehloenya, Jonny Peter, Ana Copascu, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 9, pp. 2878-2895.e6
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis
Natsumi Hama, Riichiro Abe, Andrew Gibson, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 10, Iss. 5, pp. 1155-1167.e5
Open Access | Times Cited: 139
Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions
Andrew Gibson, Pooja Deshpande, Chelsea N Campbell, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 2, pp. 289-300.e4
Open Access | Times Cited: 43
Severe cutaneous adverse reactions
Wen‐Hung Chung, Maja Mockenhaupt, Kimberly G. Blumenthal, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 18
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis
Brian M. Wei, Lindy P. Fox, Benjamin H. Kaffenberger, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 5, pp. 885-908
Closed Access | Times Cited: 35
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management
Brian M. Wei, Lindy P. Fox, Benjamin H. Kaffenberger, et al.
Journal of the American Academy of Dermatology (2023) Vol. 90, Iss. 5, pp. 911-926
Closed Access | Times Cited: 22
Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators
Mu-Tzu Chu, Wan‐Chun Chang, Shih-Cheng Pao, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 177-177
Open Access | Times Cited: 20
Updates in SJS/TEN: collaboration, innovation, and community
Madeline Marks, Ramya Krishna Botta, Riichiro Abe, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 19
Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review
Anton C. de Groot
Contact Dermatitis (2022) Vol. 86, Iss. 6, pp. 443-479
Closed Access | Times Cited: 24
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases
E. Bedouelle, Benoît Ben Saïd, F. Tétart, et al.
The Journal of Allergy and Clinical Immunology In Practice (2021) Vol. 10, Iss. 1, pp. 267-274.e5
Open Access | Times Cited: 28
Prospective Assessment of Penicillin Allergy (PAPA): Evaluating the performance of penicillin allergy testing and post-delabelling outcomes among Hong Kong Chinese
Tin Sum Li, Harris K S Hui, Andy Ka Chun Kan, et al.
Asian Pacific Journal of Allergy and Immunology (2023)
Open Access | Times Cited: 12
First-line anti-tuberculosis drug challenge reactions in DRESS in an HIV endemic setting.
Mireille Porter, Rhodine Smith, Nadine Teixeira, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024)
Closed Access | Times Cited: 4
Delayed Skin Testing for Systemic Medications: Helpful or Not?
A. Barbaud, Margarida Gonçalo, Maja Mockenhaupt, et al.
The Journal of Allergy and Clinical Immunology In Practice (2024) Vol. 12, Iss. 9, pp. 2268-2277
Open Access | Times Cited: 4
Overlapping of DRESS and Stevens-Johnson syndrome due to first-line antituberculosis drugs: a case report
Cristian Morán‐Mariños, Félix Llanos-Tejada, Rebeca Huamani-Llantoy, et al.
Therapeutic Advances in Drug Safety (2025) Vol. 16
Open Access
Results of patch testing in acute generalized exanthematous pustulosis (AGEP): A literature review
Anton C. de Groot
Contact Dermatitis (2022) Vol. 87, Iss. 2, pp. 119-141
Closed Access | Times Cited: 15
Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions
Ana Copaescu, Moshe Ben‐Shoshan, Jason A. Trubiano
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 15
Drug-induced hypersensitivity syndrome related to piperacillin-tazobactam: a case report and review of the literature
Ya Shen, Shun-shun Cui, Xiao‐bao Teng, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 3
Immediate and Delayed Hypersensitivity Reactions to Beta-Lactam Antibiotics
Ellen Minaldi, Elizabeth J. Phillips, Allison E. Norton
Clinical Reviews in Allergy & Immunology (2021) Vol. 62, Iss. 3, pp. 449-462
Closed Access | Times Cited: 18
Drug Allergy Practice Parameter Updates to Incorporate Into Your Clinical Practice
Aleena Banerji, Roland Solensky, Elizabeth J. Phillips, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 2, pp. 356-368.e5
Open Access | Times Cited: 14
Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome Caused by Apalutamide: A Case Presentation
Gabriella Martin, Evan Lambert, Gordon K Wang
Cureus (2023)
Open Access | Times Cited: 7
The assessment of severe cutaneous adverse drug reactions
Ana Copaescu, Jason A Trublano
Australian Prescriber (2022) Vol. 45, Iss. 2, pp. 43-48
Open Access | Times Cited: 11
Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs
Anton C. de Groot
Dermatitis (2022) Vol. 33, Iss. 1, pp. 16-30
Closed Access | Times Cited: 10
Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions
Stéphane Veenstra, Martha Porter, Bukiwe Thwala, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases (2023) Vol. 32, pp. 100374-100374
Open Access | Times Cited: 6
Non-IgE-Mediated Drug Hypersensitivity Reactions
Shyam Joshi, David A. Khan
Current Allergy and Asthma Reports (2021) Vol. 21, Iss. 7
Closed Access | Times Cited: 14
IFN-γ ELISpot in Severe Cutaneous Adverse Reactions to First-Line Antituberculosis Drugs in an HIV Endemic Setting
Mireille Porter, Phuti Choshi, Sarah Pedretti, et al.
Journal of Investigative Dermatology (2022) Vol. 142, Iss. 11, pp. 2920-2928.e5
Open Access | Times Cited: 9
Tackling the Patient with Multiple Drug “Allergies”: Multiple Drug Intolerance Syndrome
Autumn Guyer, Melissa Iammatteo, Merhunisa Karagic, et al.
The Journal of Allergy and Clinical Immunology In Practice (2020) Vol. 8, Iss. 9, pp. 2870-2876
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top